Home / Peptide legality / By country / India
Are peptides legal in India?
Peptides are legal in India only as government-approved prescription medicines (such as approved semaglutide GLP-1 injections dispensed under a doctor's prescription); unapproved research peptides like BPC-157 and TB-500 have no CDSCO marketing approval and cannot be lawfully sold for human use in India.
Legal status overview
Peptides are legal in India only when they are approved prescription medicines sold under a doctor's directive, while unapproved research peptides cannot be lawfully marketed for human use. India's medicines are regulated by the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI), under the Drugs and Cosmetics Act, 1940 and Rules, 1945. Approved therapeutic peptides such as semaglutide are Schedule H prescription-only drugs, whereas peptides with no CDSCO/DCGI approval fall outside the legal supply chain.
Key points
- India's national drug regulator is the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI), which regulates the sale and importation of drugs under the Drugs and Cosmetics Act framework. [1]
- Therapeutic medicines in India that fall under Schedule H of the Drugs and Cosmetics Rules, 1945 are prescription-only and cannot be sold over the counter without a registered medical practitioner's prescription. [2]
- Dispensing a Schedule H drug without a valid prescription is a criminal offence in India under the Drugs and Cosmetics Act, 1940, exposing the pharmacist and pharmacy owner to prosecution and licence cancellation. [3]
- The GLP-1 peptide semaglutide is a legally approved prescription medicine in India, having received DCGI approval for chronic weight management and other indications and marketed by multiple manufacturers. [4]
- CDSCO has approved Novo Nordisk's Wegovy® (semaglutide), making it the first and only GLP-1 receptor agonist approved in India for the MASH indication, illustrating that individual peptide drugs reach the Indian market only through formal CDSCO/DCGI approval. [5]
- Research peptides such as BPC-157 are experimental, non-approved substances with no recognized human-therapeutic marketing approval, and are prohibited in sport as non-approved substances, which in India means they cannot be lawfully sold as medicines without CDSCO/DCGI approval. [6]
- Personal importation of medicines into India is regulated by CDSCO/DCGI as part of its control over drug importation; no India-specific source was retrieved confirming an exact personal-import quantity allowance for peptides, so travelers should treat unapproved peptides as not lawfully importable for sale or non-prescription use. [1]
Compound-by-compound status
| Semaglutide (GLP-1, weight-loss/diabetes) | Semaglutide is legally approved and available in India as a DCGI-approved prescription GLP-1 medicine for chronic weight management and diabetes, sold by multiple licensed manufacturers. [4] |
|---|---|
| BPC-157 | BPC-157 has no CDSCO/DCGI marketing approval in India and is an experimental, non-approved substance, so it cannot be lawfully sold or prescribed as a medicine there. [6] |
| TB-500 (thymosin beta-4 fragment) | TB-500 is an unapproved research peptide with no therapeutic marketing approval and, lacking any CDSCO/DCGI approval, cannot be lawfully sold for human use in India. [7] |
| Human growth hormone (HGH / somatropin) | Somatropin (HGH) is generally handled as a prescription-only biologic in India, but no India-specific source was retrieved in this research directly confirming its scheduling, so this reflects inference from the Schedule H prescription framework rather than a direct citation. (no source found) |
Frequently asked questions
Can I buy peptides in India without a prescription?
No, approved therapeutic peptides in India are Schedule H prescription-only medicines that a pharmacy cannot legally sell without a doctor's prescription, and unapproved research peptides have no legal retail pathway at all. [2]
Is semaglutide (Ozempic®/Wegovy®) legal in India?
Yes, semaglutide is legal in India as a DCGI-approved prescription medicine for weight management and diabetes and is marketed by several licensed manufacturers, but it must be obtained on a doctor's prescription. [4]
Is BPC-157 legal in India?
BPC-157 is not approved by CDSCO/DCGI in India and is an experimental, non-approved substance, so it cannot be lawfully sold or prescribed as a medicine and is prohibited in competitive sport. [6]
What are the penalties for selling unapproved or prescription peptides illegally in India?
Selling a Schedule H prescription drug without a valid prescription is a criminal offence under India's Drugs and Cosmetics Act, 1940, and can lead to prosecution and cancellation of the pharmacy licence. [3]
Can I bring peptides into India from abroad for personal use?
Importation of drugs into India is controlled by CDSCO/DCGI, and unapproved research peptides have no approved status; no India-specific personal-import allowance for peptides was located in this research, so travelers should not assume such peptides can be lawfully brought in for sale or non-prescription use. [1]
Sources
- ClinRegs (NIAID) - India Regulatory Authority profile (retrieved 2026-09-22)
- JAC-Antimicrobial Resistance (Oxford Academic) - Schedule H1 prescription regulation in India (retrieved 2026-09-22)
- Medico Legal Services - Schedule H and H1 Drugs in India (retrieved 2026-09-22)
- Sun Pharma - Semaglutide DCGI Approval press release (retrieved 2026-09-22)
- Business Standard - CDSCO approves semaglutide (Wegovy®) for MASH (retrieved 2026-09-22)
- USADA - BPC-157: Experimental Peptide Creates Risk for Athletes (retrieved 2026-09-22)
- BSCG - Retailers Selling Unapproved Sports Peptides (retrieved 2026-09-22)
Last researched: 2026-09-22.